about
Lipoprotein(a) in cardiovascular diseasesSerum bone sialoprotein levels and bone metastasesSerum markers of intrahepatic cholangiocarcinomaMicroenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like CellsHomocysteine serum levels in diabetic patients with non proliferative, proliferative and without retinopathy.Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical TrialExcitability of the motor cortex in de novo patients with celiac disease.Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma.Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease.Folate status in type 2 diabetic patients with and without retinopathy.Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.Lipoprotein(a) serum levels in diabetic patients with retinopathy.Carbohydrate 19.9 antigen serum levels in liver disease.A review of transcranial magnetic stimulation in vascular dementia.Hepatic echinococcosis: clinical and therapeutic aspects.TMS follow-up study in patients with vascular cognitive impairment-no dementia.Metal fume fever.The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.Reduction of cardiovascular risk in subjects with high lipoprotein (a) levels.Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.Preserved transcallosal inhibition to transcranial magnetic stimulation in nondemented elderly patients with leukoaraiosis.Motor cortex hyperexcitability in subcortical ischemic vascular dementia.Change in Coefficient of Fatigability Following Rapid, Repetitive Movement Training in Post-Stroke Spastic Paresis: A Prospective Open-Label Observational Study.Ultrasound as point of care in management of polytrauma and its complication.Motor cortex excitability in vascular depression.Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis.Enhanced motor cortex facilitation in patients with vascular cognitive impairment-no dementia.Low levels of 17-β-oestradiol, oestrone and testosterone correlate with severe evaporative dysfunctional tear syndrome in postmenopausal women: a case-control study.Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis.Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer.Resveratrol in Patients with Minimal Hepatic Encephalopathy.Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal PainDry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity
P50
Q21284797-9C3A3253-74D3-422F-896A-1EAC4B161C7FQ28243547-5680BB5E-229D-4471-B99B-622B5B87F1F3Q28285262-EF82333E-2F0C-40D3-9398-F87D4D2C6AEDQ28546959-9CDBF962-6A9A-487E-ADB8-AECF8215DAC3Q33616748-F0B95829-D25B-4841-9927-8629D9F97ABAQ33647262-FD4D5EE2-D027-4C1F-85BC-FF1E5D56E9E8Q33951544-B21902E5-B3A5-479B-8E48-3A160CA0DC39Q35610868-FE4F642D-982F-4BDB-B742-BFED7BD7D221Q35656494-D698DAEE-91D0-4F8A-AFED-9AC1EE69C2BEQ35954630-4F678B3C-1D9E-4167-954B-517A1B01C3F6Q36192046-9DAA7454-99D3-4B36-961F-C7E13D808322Q36943438-FA6E5C0A-90BA-455E-ACF3-7F7120CA3BF7Q37299982-D8BC1B30-CF71-4B26-B4E1-19B558DAC8E2Q37829602-F45BC78D-B216-4093-B396-0DAFCD077D01Q38003142-521B79DE-7838-4D73-A378-A023230D9FC1Q39494146-B02D2EDB-CF57-4B9D-B673-272F49CC0CF1Q40242852-2EA75F49-298A-480B-8FC6-875D423A94B0Q41683709-5939DA28-A31D-45A8-8F9A-BBF12F5D2B5CQ42357350-6F4BFAF3-82BF-44E5-B0CD-3F8248F50F81Q42379723-9374073E-01D3-497C-A503-F7FD67E53F56Q42552234-5658C713-A80F-4BA9-B84F-36FAE0CA34CFQ43934065-1B7A403F-84CF-4E0F-A701-B3C06C1AF59EQ47332704-A3EFC073-D78F-4218-9312-D4C7ADC2D59FQ47737613-B13F7024-90B4-4D7D-A244-CE6D4BF27637Q48880942-582EFE4B-376E-4778-84E0-B38D21528250Q48886121-7360297F-2853-4BEB-BEA0-D9DB3F645BA5Q50551981-7C79A6B5-9C20-4977-A0BC-0006EE28E438Q50789067-1F619D35-6C78-4E97-BB0F-6C397295DE87Q51329105-4BFC0D1F-4C08-4DFF-B344-558470D53447Q51368607-C28329FF-8734-4B74-9BF8-05BAC0BD3446Q52688594-4740DEEB-6283-4185-9C09-6CA0775CCC21Q53438002-A851E005-2E51-4917-BBD2-B80D4019BE6EQ64054773-A101C3B2-AC2D-45F3-BB17-C86B3EF9C358Q96429403-26B0D356-FC73-448A-A01F-C828D4EF0ADF
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giulia Malaguarnera
@ast
Giulia Malaguarnera
@en
Giulia Malaguarnera
@es
Giulia Malaguarnera
@nl
Giulia Malaguarnera
@sl
type
label
Giulia Malaguarnera
@ast
Giulia Malaguarnera
@en
Giulia Malaguarnera
@es
Giulia Malaguarnera
@nl
Giulia Malaguarnera
@sl
prefLabel
Giulia Malaguarnera
@ast
Giulia Malaguarnera
@en
Giulia Malaguarnera
@es
Giulia Malaguarnera
@nl
Giulia Malaguarnera
@sl
P106
P1153
35364481000
P21
P31
P496
0000-0003-3655-4307